Christopher Reynolds
Penn State Milton S. Hershey Medical Center, Wake Forest University, Hershey (United States)
Papers
6
Total Citations
77
H-Index
6
About
Christopher Reynolds is a urologic surgeon and researcher whose work focuses on optimizing surgical outcomes for patients with renal cell carcinoma, particularly through robot-assisted partial nephrectomy (RAPN). His research has made significant contributions to understanding how patient-specific factors—such as obesity and perinephric fat distribution—influence perioperative risks and long-term oncologic outcomes. Reynolds led key multi-institutional studies demonstrating that positive surgical margins (PSM) following RAPN do not necessarily compromise long-term cancer recurrence or survival, a finding that has helped refine surgical decision-making and patient counseling. His work also showed that an obese body habitus does not preclude minimally invasive partial nephrectomy, expanding access to nephron-sparing surgery for a broader patient population. With over 75 citations across his most influential publications, Reynolds has helped establish evidence-based benchmarks for RAPN in complex clinical scenarios, including comparisons of outcomes for cT1a versus cT1b renal masses. His research is widely cited in the urologic oncology literature and continues to inform best practices in robotic kidney surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6